Association Between Body Mass Index and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement (TAVR) with Edwards SAPIEN™ 3 TAVR Valves: A Single-Center Experience
Authors:
Open Access
- 15 July 2019
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 11 (7) , e5142
Abstract
Transcatheter aortic valve replacement (TAVR) can be complicated with a high-degree atrioventricular block requiring a permanent pacemaker (PPM) in 5% - 25% of patients. Association between body mass index (BMI) and pacemaker implantation has not been extensively studied. We compared standard BMI classes with the odds of requiring a PPM implantation in patients undergoing TAVR with Edwards SAPIEN™ 3 valves (ESV3) (Edwards Lifesciences, Irvine, CA, USA). Our study involved a single-center retrospective cohort analysis of 449 patients undergoing TAVR from December 2012 to April 2018. First, we excluded patients with a TAVR procedure done with valves other than the ESV3 (127 patients). Second, patients with a prior PPM or an implantable cardioverter-defibrillator (37 patients) were excluded. Finally, patients with an aborted procedure and surgical conversion were excluded (16 patients). The final sample size was 269. The primary outcome was pacemaker implantation. Statistical analysis was done using the Chi-square test, T-test, and adjusted logistic regression. Of the 269 patients (50.6% males; mean age of 79.5 ± 8.7 years; mean Society of Thoracic Surgeons (STS) score: 6.2), pacemaker implantation was performed in 17 patients (6.3%). Time to pacemaker implantation was 1.3 days. Patients were divided into four categories based on their BMI: as underweight (BMI < 25; 67 patients), normal (BMI: 25 to ≤ 30; 87 patients), overweight (BMI: 30 to ≤ 35; 60 patients), and obese (BMI ≥ 35; 55 patients). Pacemaker implantation was significantly higher in patients with a BMI of > 30 (13 vs. 4, p = 0.037). After logistic linear regression, the odds of getting a PPM after TAVR were significantly higher in patients who were overweight (odds ratio (OR): 12.77, p = 0.024; confidence interval (CI): 1.39 - 17.25) and obese (OR: 15.02, p = 0.036, CI: 1.19 - 19.92). Our study demonstrates that increased BMI is a possible risk factor for a high-degree atrioventricular block in patients receiving ESV3.Keywords
This publication has 15 references indexed in Scilit:
- 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve ReplacementJACC, 2016
- Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart ValveJACC: Cardiovascular Interventions, 2016
- Effect of Body Mass Index <20 kg/m2 on Events in Patients Who Underwent Transcatheter Aortic Valve ReplacementThe American Journal of Cardiology, 2015
- Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVRJACC, 2014
- Comparison of Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients Aged ≥90 Years Versus <90 YearsThe American Journal of Cardiology, 2012
- Factors Predicting and Having an Impact on the Need for a Permanent Pacemaker After CoreValve Prosthesis Implantation Using the New Accutrak Delivery Catheter SystemJACC: Cardiovascular Interventions, 2012
- Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantationAmerican Heart Journal, 2012
- Atrioventricular Block After Transcatheter Balloon Expandable Aortic Valve ImplantationJACC: Cardiovascular Interventions, 2008
- Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight LossCirculation, 2006
- Obesity Cardiomyopathy: Pathophysiology and Evolution of the Clinical SyndromeThe American Journal of the Medical Sciences, 2001